Ivan dikic google scholar

Ivan dikic twitter
Inga đikić
Ivan Đikić, Director of the Institute of Biochemistry II at Goethe University Frankfurt am Main, has been appointed as Fellow of the Max Planck Society.

•

Speaker

Ivan Đikić, M.D., Ph.D. is Professor of biochemistry at Goethe University and a Fellow of Max Planck Institute for Biophysics in Frankfurt. The Đikić lab studies molecular principles of ubiquitin biology and autophagy and explores pathological alterations in these pathways related to human disease development such as cancer, neurodegeneration and infection. His recent interests focus on remodeling of cellular organelles, including ER and mitochondria, via selective autophagy pathways. He is an elected member of the EMBO, the German National Academy of Sciences Leopoldina, the European Academy, and the American Academy of Arts and Sciences. For his scientific work he received the Ernst Jung Prize for Medicine and the Leibniz Prize of the DFG. Ivan Đikić is committed to education of the next generations of young scientists globally.

Web: https://biochem2.com/research-group/molecular-signaling

LinkedIn: https://www.linkedin.com/in/ivan-đikić-a7b53527/

Twitter: @iDikic2

« Go Back

•

Ivan Đikić

Croatian cancer researcher (born 1966)

Ivan Đikić (born 28 May 1966^[1]) is a Croatian-German molecular biologist who is the Director of the Institute of Biochemistry II at Goethe University Frankfurt.

Scientific career

In 1991, he earned his MD degree from the Faculty of Medicine at the University of Zagreb.^[2] After finishing his medical studies, he continued to pursue his PhD thesis in molecular biology at the University of Zagreb and at the New York University School of Medicine until 1997. He continued to work as a postdoctoral fellow in the laboratory of Joseph Schlessinger in New York from 1995 to 1997 before starting his own group at the Ludwig Institute for Cancer Research in Uppsala (Sweden).^[2]

In 2002, Đikić was appointed as a Professor at Goethe University Frankfurt. He followed in Werner Müller-Esterl's footsteps as Director of the Institute of Biochemistry II in 2009. In addition, Đikić was the first Scientific Director (2009–2013) of the Buchmann Institute for Molecular Life Sciences, a cross-faculty, interd

•

Prof. Dr. Ivan Đikić

Max Planck Fellow

We are happy to share our knowledge and infrastructure with Prof. Ivan Đikić.

The molecular biologist and biochemist Ivan Đikić, Director of theInstitute of Biochemistry II at Goethe University Frankfurt am Main, has been appointed as Fellow of the Max Planck Society. He started his term at the Max Planck Institute of Biophysics in October 2018.
The Max Planck Fellow Programme promotes cooperation between outstanding university professors and Max Planck Society researchers.
The appointment as Max Planck Fellow entails the supervision of a small working group at a Max Planck Institute for a five years term.
Research in the Đikić group is centered around two major cellular quality control pathways: the ubiquitin system and autophagy. As such they provide protection against various human diseases and are involved in almost all cellular signaling processes. The group covers a wide range of expertise to reveal structure-function relationships. Recently, theĐikić Molecular Signaling Group revealed a novel